Source: MedRobot
Reprint Requirements: Can be reprinted 24 hours after the first release, with source indicated
Summary and Analysis of Major Events in January 2022
Endoscopic Surgery “Triumvirate”
This month, following the registration certificate obtained by Weigao’s MiaoShou endoscopic robot, the minimally invasive surgical robot TUMAI received the NMPA registration certificate. According to the announcement released by Minimally Invasive Robotics (02252.HK) on January 27, this is currently the first and only four-arm endoscopic surgical robot developed by a Chinese company and approved for market.
The endoscopic surgical robot has entered a stage of “triumvirate” with one foreign company and two domestic companies: the endoscopic surgical robots from Da Vinci, Weigao, and Minimally Invasive Robotics can all be sold in China.
Unlike the surgical procedures approved for Weigao’s MiaoShou, which are concentrated in general surgery, the indications for the Minimally Invasive TUMAI endoscopic surgical robot are in urology. According to reports from Intuitive Surgical, urology is the department with the most applications of endoscopic surgical robots, and robotic surgery has significant advantages over traditional methods.
In the United States, the penetration rate of robot-assisted radical prostatectomy has exceeded 70%. Due to less intraoperative bleeding and faster surgical speed, it effectively preserves structures related to urinary control, promotes early recovery of urinary control postoperatively, and maximizes recovery of functional capabilities. Radical prostatectomy has become a classic procedure for robotic surgery.
Neurosurgery Surgical Robots Are More Mature, Core Components Are Domestically Sourced
According to the National Medical Products Administration, this month, Baihui Weikang and Huake Precision both had neurosurgery surgical navigation systems approved.
Reports indicate that Baihui Weikang has achieved domestic production of core components for surgical robots, including optical tracking devices and robotic arms (Si Yu adds: The main modules commonly found in the surgical robot industry, NDI and UR, are all imported, constrained by trade policies and high pricing).
Percutaneous Surgical Robot Company EDDA Health Resubmits Application for Listing on Hong Kong Main Board
EDDA Technology’s IQQA-Guide was the first domestic device approved by the NMPA in January 2020 for puncture surgery navigation for adult lung and abdominal soft tissue solid organs. Compared to conventional CT-guided methods, it can improve puncture accuracy, reduce the number of needle insertions and CT scans, and has significant clinical application value.
Wishing the founders of this 90% gross margin robot company a successful IPO.
One
Policy Dynamics
CyberKnife | 48 Medical Service Items in Shanghai Included in Basic Medical Insurance Payment Scope | Policy
Two
IPO
Intelligent Surgical Robot Company EDDA Plans IPO on Hong Kong Main Board
On January 11, 2022, EDDA Health Medical Technology Holdings Limited (hereinafter referred to as “EDDA Health”) resubmitted its prospectus to the Hong Kong Stock Exchange, preparing for an IPO in Hong Kong, with Morgan Stanley and CICC as its lead underwriters.
Intelligent Surgical Robot Company EDDA Plans IPO on Hong Kong Main Board | IPO
Three
Investment Heat Remains High
Surgical Robot CompanyCaira Surgical Secures $5 Million Seed Round Financing
Caira Surgical secured $5 million in seed funding during an oversubscribed seed financing round last month. Caira’s investors include smart-money investors and strategic medical technology investors. Caira Surgical is developing new standards for navigation and robotic solutions for joint replacement surgery. Caira’s proprietary technology aims to revolutionize the availability, safety, and accessibility of advanced surgical navigation and robotics for orthopedic surgery. The company’s first product is a groundbreaking sub-millimeter precision radar tracking system for knee replacement surgery. This system utilizes advanced radar technology to overcome line-of-sight interference and eliminate the invasive surgical hardware and high-cost, large-footprint capital equipment inherent in existing surgical tracking systems.
Orthopedic Surgical Robot | Surgical Robot Company Caira Surgical Secures $5 Million Seed Round Financing | Financing
Mixed Reality Surgical Navigation LeaderJinse MedicalSecures Tens of Millions in A and A+ Round Financing
Changzhou Jinse Medical Information Technology Co., Ltd. recently completed tens of millions in A and A+ round financing. The two rounds of financing were closely spaced, with the A round led by Weilin Capital, and Changchuan Investment and Probe Capital participating; the A+ round was exclusively invested by well-known industrial capital Shangyuan Capital, with Probe Capital serving as the exclusive financial advisor. The funds raised will be used to accelerate the R&D and commercialization of Jinse Medical’s orthopedic and oncology product pipeline, as well as to expand the company’s subsequent team.
Surgical Navigation | Mixed Reality Surgical Navigation Leader Jinse Medical Secures Tens of Millions in A and A+ Round Financing | Financing
Surgical Robot CompanyYuanhua IntelligentCompletes Hundreds of Millions in B Round Financing
Yuanhua Intelligent Technology (Shenzhen) Co., Ltd. recently completed hundreds of millions in B round financing. This round was led by Cornerstone Capital, with original shareholders Shenzhen Venture Capital and Sequoia China continuing to support, and several well-known investment institutions including Guoke Jiahe and Wanhui Capital participating. The funds raised will support the comprehensive commercialization layout of the company’s orthopedic surgical robots, accelerate the clinical progress of gastrointestinal products and natural orifice surgical robots, and promote the final testing and commercial application of the company’s self-developed collaborative robotic arms.
Orthopedic Surgical Robot | Surgical Robot Company Yuanhua Intelligent Completes Hundreds of Millions in B Round Financing | Financing
Weiya MedicalCompletes Tens of Millions in A Round Financing
Recently, leading domestic minimally invasive vascular interventional surgical robot company Weiya Medical completed tens of millions in A round financing. This round was led by Boyuan Capital, with domestic vascular intervention leader Guichuang Tongqiao (02190.HK) as a strategic investor, and Yicheng Capital serving as a long-term exclusive financial advisor. The funds raised will be used for the iterative development of the company’s vascular interventional surgical robots, expansion of product indications, and acceleration of clinical progress. Meanwhile, Weiya Medical signed a strategic cooperation agreement with Guichuang Tongqiao, which will continuously empower Weiya Medical based on its resources in the vascular intervention field, jointly accelerating the product development, clinical cooperation, registration application, and commercialization progress of Weiya Medical’s vascular interventional surgical robots to meet broader clinical needs in vascular intervention surgery.
Vascular Interventional Surgical Robot | Weiya Medical Completes Tens of Millions in A Round Financing | Financing | Domestic
BiozhishengSecures Millions in A Round Financing, Led by Sequoia China
Orthopedic intelligent diagnosis and treatment company Biozhisheng recently completed millions in A round financing, led by Sequoia China, with several existing shareholders including Shukun Technology, Qiji Chuangtan, and HKX Fund participating. The funds will primarily be used to accelerate the scientific transformation of its intelligent orthopedic robots and drug-loaded implants, fully promote the clinical trials and domestic and international registration of several Class III medical device products, rapidly increase market penetration, and establish nationwide marketing channels to provide better treatment options for a large number of orthopedic patients in China, especially elderly orthopedic patients.
Intelligent Orthopedic Robot | Biozhisheng Secures Millions in A Round Financing, Led by Sequoia China | Financing
French Exoskeleton CompanyWandercraftSecures $45 Million in C Round Financing
According to TechCrunch and ZDNet, French exoskeleton company “Wandercraft” announced yesterday that it has completed $45 million in C round financing. This round was co-led by American company Quadrant Management and existing investor Bpifrance, with Quadrant’s participation indicating that the company’s business scope has expanded from Europe to the United States. The total amount of financing for the company has reached nearly $76 million.
Exoskeleton Robot | French Exoskeleton Company “Wandercraft” Secures $45 Million in C Round Financing | Financing
Fourier IntelligentCompletes 400 Million Yuan in D Round Financing, Led by SoftBank Vision
Fourier Intelligent recently announced the completion of 400 million Yuan in D round financing, led by SoftBank Vision Fund II, with Saudi Aramco’s venture capital fund Prosperity7 Ventures and Yuanjing Capital participating. Fourier Intelligent is the first company in the rehabilitation robot field to complete D round financing, setting a record for the highest single round financing in this field. Fourier Intelligent’s founder and CEO Gu Jie stated that this round of financing will be used to develop intelligent robot technology, expand advantages, accelerate the global rollout and popularization of rehabilitation robot products, and continuously enhance rehabilitation service capabilities to meet customer needs.
Rehabilitation Robot | Fourier Intelligent Completes 400 Million Yuan in D Round Financing, Led by SoftBank Vision | Financing
Five
Clinical Progress in an Orderly Manner
Surgical Sharp Medical+ Four Medical Institutions Launch Clinical Projects for Endoscopic Surgical Robots
On January 6, a clinical project for a single-port laparoscopic surgical robot was launched at the Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University (hereinafter referred to as: Shanghai Ninth Hospital). This clinical project for the single-port laparoscopic surgical robot is hosted by four medical institutions in China: Shanghai Chang Hai Hospital, Shanghai Jiao Tong University Ninth People’s Hospital, Nanjing Medical University Second Affiliated Hospital, and Zhejiang University First Affiliated Hospital. The project leader, Dr. Xu Bin from the Urology Department of Shanghai Ninth Hospital, stated in an interview on January 6 that the single-port laparoscopic technology has entered the robotic era, allowing for more minimally invasive and precise urological laparoscopic surgeries. He believes that the launch of this project will better meet patients’ needs for rapid recovery and aesthetic considerations.
Single-Port Laparoscopic Surgical Robot | Surgical Sharp Medical + Four Medical Institutions Launch Clinical Projects for Endoscopic Surgical Robots | Clinical
LancetAI-Assisted Total Hip Replacement Robot Officially Launches Clinical Trials
On December 30, 2021, the research meeting for the AI-assisted total hip replacement surgery three-dimensional planning system (Lancet AI Hip) developed by Hangzhou Lancet Robot was successfully held, marking the official launch of the clinical trials for the registration of the Lancet AI-assisted total hip replacement surgery three-dimensional planning system in China.
Digital Orthopedics | AI-Assisted Total Hip Replacement Surgery Three-Dimensional Planning System Officially Launches Clinical Trials | Clinical | Lancet Robot
First FDA-ApprovedDental Surgery System Yomi Completes 10,000 Implant Surgeries
Neocis, Inc. announced that clinicians have used the Yomi® dental robot platform to place over 10,000 dental implants. Yomi received FDA approval for implant surgery in 2016 and for full dental orthodontic surgery in 2020. Yomi® is the first and only FDA-approved robotic-assisted dental surgery system, providing assistance during the planning (preoperative) and surgical (intraoperative) phases of dental implant surgeries. This system offers clinicians unique capabilities to accurately plan and place dental implants, with physical tactile guidance not available in other treatment options.
Dental Robot | First FDA-Approved Dental Surgery System Yomi Completes 10,000 Implant Surgeries | Clinical
Jingfeng MedicalCompletes First Animal Experiment of Domestic Dual-Arm Bronchoscopic Surgical Robot
On December 31, Shenzhen Jingfeng Medical Technology Co., Ltd. successfully completed the animal experiment of the dual-arm bronchoscopic surgical robot. This experiment was completed by experts and doctors from relevant professional departments, in collaboration with the Jingfeng project team, using the Jingfeng® self-developed dual-arm bronchoscopic surgical robot. The completion of this experiment signifies Jingfeng Medical’s leading position in another field beyond multi-port and single-port robots.
Bronchoscopic Surgical Robot | Jingfeng Medical Completes First Animal Experiment of Domestic Dual-Arm Bronchoscopic Surgical Robot | Clinical
Minimally Invasive Medical TUMAI Single-ArmConfiguration Surgical Robot Completes First Domestic Clinical Verification
Recently, Lanzhou University First Hospital completed preclinical testing on the domestic TUMAI single-arm configuration surgical robot system and successfully performed a laparoscopic cholecystectomy using the single-port laparoscopic surgical robot in collaboration with Beijing Friendship Hospital Affiliated to Capital Medical University, achieving the first human clinical verification of the domestic single-arm configuration surgical robot, marking another significant breakthrough for Lanzhou University First Hospital in the field of robotic minimally invasive surgery. The robot used in this surgery was developed by Shanghai Minimally Invasive Medical Robot (Group) Co., Ltd. The surgical team has successfully performed gallbladder removal, partial liver resection, gastrointestinal anastomosis, and other visceral removal and suturing surgeries. Through thorough testing, the robot’s end effector can flexibly perform clamping, cutting, electrocoagulation, suturing, and knotting operations, and the development team has fully verified the clinical stability, operational convenience, and safety of the minimally invasive surgical robot, with functionality meeting clinical needs and performance reaching a leading level in China.
Single-Arm Surgical Robot | Minimally Invasive Medical TUMAI Single-Arm Configuration Surgical Robot Completes First Domestic Clinical Verification | Clinical
RobocathCompletes First Robot-Assisted Coronary Angioplasty in Europe with R-One
On January 11, 2022, Robocath completed its first European clinical study – “R-Evolution”, to demonstrate the safety and efficacy of robot-assisted coronary angioplasty using R-One. R-One™ is the first solution developed by Robocath. It uses unique bionic technology to optimize the safety of robot-assisted coronary angioplasty. This medical procedure involves reconstructing the blood vessels of the myocardium by inserting one or more implants (stents) into the artery supplying blood to it. This type of procedure is performed every 30 seconds somewhere in the world. R-One is designed for precise operation and execution of specific actions, creating better interventional conditions. Due to its open architecture, R-One is compatible with market-leading devices and catheter laboratories.
Vascular Surgery Robot | Robocath Completes First Robot-Assisted Coronary Angioplasty in Europe with R-One | Clinical
LancetRobPath Robot Completes First Robot-Assisted Total Knee Replacement Surgery in Jiangsu
Recently, Nanjing Drum Tower Hospital completed a robot-assisted total knee replacement surgery, which was performed by Professor Jiang Qing’s team with the assistance of the Lancet RobPath knee replacement surgical robot. This was the first domestic robot-assisted total knee replacement surgery conducted in Jiangsu Province. The successful implementation of this surgery has accumulated successful practical experience for Nanjing Drum Tower Hospital in the clinical application of robot-assisted total knee replacement surgery, marking the hospital’s commitment to medical technology innovation and leading the wave of domestic high-end medical equipment.
Orthopedic Surgical Robot | Lancet RobPath Robot Completes First Robot-Assisted Total Knee Replacement Surgery in Jiangsu | Clinical
Zhu ZhengSurgical Robot Completes First Minimally Invasive Spinal Fusion Surgery in Bazhong City
In the orthopedic operating room of Bazhong Central Hospital, a “new doctor” has arrived, different from the past, this doctor is a surgical robot, which successfully assisted doctors in completing the first minimally invasive spinal fusion surgery in Bazhong City.
Orthopedic Surgical Robot | Zhu Zheng Surgical Robot Completes First Minimally Invasive Spinal Fusion Surgery in Bazhong City | Clinical
Minimally Invasive® TUMAI® Robot Successfully CompletesThoracic Surgery Registration Clinical Trial
On January 16, 2022, the TUMAI® laparoscopic surgical robot developed by Shanghai Minimally Invasive Medical Robot (Group) Co., Ltd. successfully completed the clinical trial for safety and efficacy in thoracic surgery. This project involved Professor Luo Qingquan from Shanghai Chest Hospital, Professor Yu Bentong from Nanchang University First Affiliated Hospital, Professor Xu Jinzhi from Harbin Medical University Fourth Affiliated Hospital, and Professor Gou Yunjie from Gansu Provincial People’s Hospital. Thus, TUMAI® became the first domestic laparoscopic surgical robot to complete registration clinical trial case enrollment in the thoracic field.
Minimally Invasive® TUMAI® Robot Successfully Completes Thoracic Surgery Registration Clinical Trial
Lancet Robvas RobotFirst Group of Coronary and Peripheral Interventions Animal Trials Successfully Completed
On January 15, 2022, in Shanghai, the Lancet Robot team completed multiple animal trials of the Robvas vascular intervention robot-assisted coronary and peripheral interventions, with the core functions of the Robvas vascular intervention robot being recognized by well-known clinical experts. Interventional physicians achieved precise control of interventional consumables (guide wires, catheters, balloons, stents) in a radiation-free environment through a real-time master-slave control system and visual feedback system, successfully completing the surgeries.
Vascular Intervention Robot | Lancet Robvas Robot First Group of Coronary and Peripheral Interventions Animal Trials Successfully Completed | Animal Trials
Nanjing Drum Tower Hospital Successfully Completes Clinical Trial Surgeries for Mona LisaProstate Puncture Robot
On January 21, 2022, the Mona Lisa prostate puncture robot positioning system (hereinafter referred to as “Mona Lisa”) developed by Shanghai Minimally Invasive Medical Robot (Group) Co., Ltd. (hereinafter referred to as “Minimally Invasive® Robot”) and Singapore Biobot Surgical Pte. Ltd. jointly established in China successfully completed all clinical trial surgeries for robot-assisted prostate puncture biopsy at Nanjing University Medical School Affiliated Drum Tower Hospital (hereinafter referred to as “Nanjing Drum Tower Hospital”), marking a phased progress in the multi-center clinical project of the Mona Lisa prostate puncture robot positioning system.
Minimally Invasive Robot | Nanjing Drum Tower Hospital Successfully Completes Clinical Trial Surgeries for Mona Lisa Prostate Puncture Robot | Clinical
CMR Surgical: Versius Surgical Robot Successfully Applied in200 Thoracic Cases
CMR Surgical (CMR) announced that its Versius surgical robot system has been approved for thoracic use to assist surgeons in performing minimally invasive surgeries for patients undergoing lung, thymus, and esophageal surgeries. Following a gradual introduction of specific cases and surgical options, Versius has now been used in approximately 200 thoracic cases in Europe, India, and Australia, including esophageal myotomy, lobectomy, and thymectomy.
Thoracic Surgical Robot | CMR Surgical: Versius Surgical Robot Successfully Applied in 200 Thoracic Cases | Clinical
Smith & Nephew: CORI Surgical System Expands toTotal Hip Replacement Surgery
Global medical technology company Smith & Nephew announced the expansion of its CORI surgical system (the industry’s most advanced and efficient surgical system) indications, with the handheld robotic solution for total knee replacement surgery now including total hip replacement surgery (THA). Smith & Nephew’s RI hip navigation system aims to maximize accuracy and reproducibility by providing patient-specific component alignment for THA, now available for its CORI system.
Orthopedic Surgical Robot | Smith & Nephew: CORI Surgical System Expands to Total Hip Replacement Surgery | Clinical
Six
Product/Company Dynamics
Lancet Officially Releases the World’s First Soft-Sensing Vascular Intervention Surgical Robot Robvas
The vascular intervention robot Robvas is the fourth surgical robot released by Lancet Robot following the hip replacement surgical robot RobPath Hip, knee replacement surgical robot RobPath Knee, and dental implant surgical robot Dencore. The release of Robvas marks Lancet Robot as the only medical robot innovation company globally deeply engaged in four major surgical tracks: hip replacement, knee replacement, dental implants, and vascular interventions.
Vascular Intervention Surgical Robot | The World’s First Soft-Sensing Vascular Intervention Surgical Robot Robvas Officially Released | Product Dynamics | Lancet Robot
Titan Medical Completes Final Milestone of Development Agreement with Medtronic
Titan Medical (Nasdaq: TMDI; TSX: TMD) is a medical technology company focused on the development and commercialization of innovative single-port robotic-assisted surgical systems and technologies. On January 4, 2022, it announced that it has successfully completed the final milestone under its development and licensing agreement with the world-leading Medtronic plc. With the successful completion of the agreement, Titan will receive a licensing fee as planned in exchange for Medtronic’s development technology license, while the guaranteed loan provided by Medtronic to Titan will be canceled. The technology developed under the Medtronic development and licensing agreement can be used by both Titan and Medtronic in their respective businesses. As a result of this development activity, Titan has submitted several new patent applications and retains the rights to independently commercialize these technologies globally for its own Enos™ robotic single-port surgical system.
Single-Port Surgical Robot | Titan Medical Completes Final Milestone of Development Agreement with Medtronic | Company Dynamics
Memic Announces Adoption of Hominis Surgical System by Three U.S. Hospitals in Q4 2021
On January 6, 2022, Memic Innovative Surgery Inc (Memic) announced that HCA Florida Healthcare’s Kendall Regional Medical Center, AdventHealth Celebration, and Jackson Memorial’s The Women’s Hospital have purchased the Hominis® Surgical System for single-site, natural orifice laparoscopic-assisted transvaginal surgeries, including benign hysterectomies. Hominis is the first and only FDA-authorized surgical robot with miniature human-like arms, shoulders, elbows, and wrist joints, providing human-level flexibility and 360-degree joints.
Laparoscopic Surgical Robot | Memic Announces Adoption of Hominis Surgical System by Three U.S. Hospitals in Q4 2021 | Market | Gynecology
Johnson & Johnson Announces Partnership with Microsoft to Create a Digital Surgical Ecosystem
Johnson & Johnson Medical Devices Companies (JJMDC) announced a partnership with Microsoft to further realize and expand JJMDC’s secure and compliant digital surgical ecosystem. Microsoft Cloud will help JJMDC achieve its vision of driving innovation, improving skills, enhancing workflows, and augmenting surgical decision-making, thereby providing a better overall customer experience and improving patient and economic outcomes.
Latest | Johnson & Johnson Announces Partnership with Microsoft to Create a Digital Surgical Ecosystem | Leading Enterprises
Quantum Surgical’s Epione Surgical Robot Successfully Enters the World’s First Cancer Treatment Center
On January 11, 2022, Quantum Surgical announced that the internationally renowned Gustave Roussy Cancer Center has become the first hospital in the world to use the Epione device for minimally invasive robotic surgery. The Epione device is a medical robot used for liver cancer treatment. This is the first contract between the innovative medical robot developer Quantum Surgical and Europe’s leading cancer center Gustave Roussy (Villejuif, France), aimed at enabling more patients to benefit from Epione for minimally invasive treatment of abdominal tumors. This technology involves inserting a needle into the skin to destroy tumors.
Oncological Surgical Robot | Quantum Surgical’s Epione Surgical Robot Successfully Enters the World’s First Cancer Treatment Center | Market
Titan Medical Partners with Benchmark to Manufacture Enos Robot System
Titan Medical announced that it has signed a manufacturing and supply agreement with Benchmark Electronics, Inc. to produce Titan’s innovative Enos™ robotic single-port surgical system workstation and patient cart. These solutions manufactured by Benchmark will integrate with Titan’s proprietary and patent-pending cameras and multi-joint instruments, which are planned to be manufactured by Titan at its facility in Chapel Hill, North Carolina.
Single-Port Surgical Robot | Titan Medical Partners with Benchmark to Manufacture Enos Robot System
Inovus Medical Launches High-Fidelity Hysteroscopy Simulator
Inovus Medical® announced the launch of its new high-fidelity hysteroscopy simulator HystAR™. This simulator combines the company’s patented augmented reality technology and cloud-based learning platform with its simulated tissue models’ natural tactile feedback to provide highly realistic, scalable, and trackable hysteroscopy skills training.
AR Surgical Training System | Inovus Medical Launches High-Fidelity Hysteroscopy Simulator
Philips Integrates Cloud-Based AI and 3D Mapping into Zenition Mobile C-Arm System
Recently, Philips announced that doctors can now access advanced 3D imaging capabilities through its image-guided treatment mobile C-arm system – Zenition, improving clinical accuracy and efficiency, and aiming to enhance outcomes for patients undergoing endovascular treatments. The company has signed a strategic partnership with Cydar, a UK-based cloud-based programmatic software provider for real-time surgical planning and guidance.
Surgical Image Guidance | Philips Integrates Cloud-Based AI and 3D Mapping into Zenition Mobile C-Arm System | Innovation
PROCEPT BioRobotics Partners with Northside Healthcare for Multi-System, Hospital Agreement
PROCEPT BioRobotics has installed five AquaBeam robotic systems in all of Northside Health Systems’ state-of-the-art surgical facilities. AquaBeam is the first and only image-guided, non-thermal robotic therapy for treating lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH).
BPH Surgical Robot | PROCEPT BioRobotics Partners with Northside Healthcare for Multi-System, Hospital Agreement
2021 Da Vinci Surgical Robot Agreement Signing Situation
According to incomplete statistics, the number of Da Vinci surgical robot agreements signed in mainland China in 2021 was 30 units, in addition to one agreement signed for a surgical robot virtual operating system, which is lower than the 61 units in 2020 and 59 units in 2019. The total number of maintenance agreements signed for robots throughout the year was 60.
2021 Da Vinci Surgical Robot Agreement Signing Situation
Smith & Nephew Acquires Engage Surgical for $135 Million, Expanding U.S. Market
Global medical technology company Smith & Nephew announced the acquisition of Engage Surgical, the only commercial non-bone cement single ankle (partial) knee system in the U.S. This acquisition transforms the business through innovation and acquisition while providing differentiation to customers, strongly supporting Smith & Nephew’s growth strategy. The Engage surgical partial knee system is a novel modern non-bone cement knee implant that drives better long-term fixation potential through biological integration, shorter surgical times, and a shift to outpatient surgical centers (ASC) to serve a revitalized niche market.
Smith & Nephew Acquires Engage Surgical for $135 Million, Expanding U.S. Market | Leading Dynamics
Johnson & Johnson Partners with Tianzhihang! Launches New Viper Prime (TM) Tianji Spine Robot Surgical Integration Solution
Recently, Johnson & Johnson Medical partnered with Tianzhihang, a leading domestic orthopedic surgical robot company, to jointly develop the new Viper Prime (TM) Tianji spine robot surgical integration solution, which has officially launched and is in use. This innovative product successfully integrates Johnson & Johnson’s globally advanced minimally invasive implant system Viper Prime (TM) with Tianzhihang’s Tianji surgical robot, providing higher efficiency and intelligent services for clinical doctors, benefiting more spine patients.
Johnson & Johnson Partners with Tianzhihang! Launches New Viper Prime (TM) Tianji Spine Robot Surgical Integration Solution | Leading Dynamics
CMR Surgical’s Versius Surgical Robot Commercialization Takes Another Step, Enters Pakistan SIUT
Global surgical robot company CMR Surgical announced that its next-generation surgical robot system Versius has successfully completed several urological surgeries at the Sindh Institute of Urology and Transplantation (SIUT) in Pakistan. SIUT is a well-known charity that provides free state-of-the-art medical services to all patients, regardless of their background or wealth, promoting the treatment of kidney diseases, urology, and nephrology, tumor treatment, liver and gastrointestinal diseases, and organ transplantation.
CMR Surgical’s Versius Surgical Robot Commercialization Takes Another Step, Enters Pakistan SIUT | Market
Kangji Medical Plans to Acquire 35% Equity of Weijing Medical Robot for 363 Million Yuan
On January 18, 2022, Kangji Hong Kong (09997.HK) conditionally agreed to subscribe for 32.75% equity of the target company based on a fully diluted basis for 340 million Yuan (approximately 417 million Hong Kong dollars); and each seller conditionally agreed to sell, and Kangji Hong Kong conditionally agreed to acquire 1.125% equity of the target company based on a fully diluted basis for 11.435 million Yuan (totaling 22.87 million Yuan, approximately 28.036 million Hong Kong dollars, acquiring a total of 2.25% equity) (acquisition matter).
Kangji Medical Plans to Acquire 35% Equity of Weijing Medical Robot for 363 Million Yuan
Overcoming Needle Fear, Intelligent Needle-Free Vaccine Injection Robot is Here!
On January 21, 2022, the first intelligent needle-free vaccine injection robot in China was unveiled by Feixi Technology, developed by a team led by Associate Professor Qi Peng from Tongji University in collaboration with Beijing Keshur Medical Technology Co., Ltd., Feixi Technology, and the Chinese Cardiovascular Doctors Innovation Club. This is also the first product combining artificial intelligence and needle-free injection technology in the post-pandemic era.
Injection Vaccine Robot | Overcoming Needle Fear, Intelligent Needle-Free Vaccine Injection Robot is Here! | Innovation
Intuitive Surgical Q4 2021 Performance, Revenue of $1.6 Billion
Intuitive reported revenue of $1.6 billion for the three months ending December 31, 2021, with a profit of $380.6 million, or $1.04 per share, a year-on-year revenue growth of 10.5%, slightly increasing its profit by about $100,000. Adjusted to exclude one-time items, earnings per share were $1.30, beating Wall Street’s expectations by 2 cents, while revenue exceeded analysts’ expectations by about 0.8%.
Da Vinci Surgical Robot | Intuitive Surgical Q4 2021 Performance, Revenue of $1.6 Billion
Six
Registration Approval
Huake Precision Neurosurgery Surgical Navigation System Approved for Market
After review by the National Medical Products Administration, the registration application for the innovative product “Neurosurgery Surgical Navigation System” produced by Huake Precision (Beijing) Medical Technology Co., Ltd. was approved. This product consists of an infrared camera, workstation, bracket, positioning components (probe, reference frame, connector, reflective ball, surgical instrument adapter), laser probe, handheld laser pointer, foot switch, and automatic positioning device, used for navigation and directional positioning of neurosurgical instruments and implants.
Surgical Navigation System | Huake Precision Neurosurgery Surgical Navigation System Approved for Market | Registration
FDA Approves First AI-Driven Augmented Reality Guidance System for Spine Surgery
On January 18, 2022, Surgalign Spine Technologies, headquartered in Deerfield, announced that the FDA approved its HOLOPortal surgical guidance system for use in lumbar spine surgery. The HOLO Portal system is the world’s first AI-driven augmented reality guidance system for spine surgery and is the first clinical application of Surgalign’s HOLOTM AI digital health platform.
AR Surgical System | FDA Approves First AI-Driven Augmented Reality Guidance System for Spine Surgery | Registration
Minimally Invasive Laparoscopic Surgical Robot Receives Certification! Overview of 15 Global Laparoscopic Surgical Robots
On January 27, 2022, the National Medical Products Administration announced the certification of the minimally invasive laparoscopic surgical robot. This is the second laparoscopic surgical robot registration certificate in China, following the approval of the Weigao surgical robot for abdominal laparoscopic surgery on October 27, 2021.
Minimally Invasive Laparoscopic Surgical Robot Receives Certification! Overview of 15 Global Laparoscopic Surgical Robots
Seven
Industry Personnel
Personnel Changes
Latest | Shi Saike Medical China Region Director and General Manager Ma Min Joins Tianzhihang
Former GE Healthcare Greater China CT Business Unit General Manager Chen Zongxi Appointed Chief Business Officer of Jingfeng Medical
Former Intuitive Surgical Sales Champion Chris Fronk Appointed Vice President of Sales for THINK Surgical in the U.S.
Former Olympus Global General Manager Manisha Shah-Bugaj Appointed Chief Operating Officer of Activ Surgical
Executives Say:
Former Da Vinci Executive Predicts New Opportunities, Ruixin Medical Releases AI + Vascular Intervention Robot
Interview | Thirteen Years, Together Through Mountains and Seas – Ruimi Surgical Robot on the Road
Soft Tissue Surgical Robots, Intuitive Surgical, Medtronic, Johnson & Johnson, Who Will Become the Next Winner? | CEO Interview
XACT Chen Laiwen: Percutaneous Surgical Robot Technology
Doctors Say:
Interview | Dr. Chen Cheng from Peking University First Hospital: Robotic Surgery Realizes the Sublimation and Return of Surgical Concepts | Doctor Column
Eight
Industry and Technology
Endoscopic Surgical Robots | The Era of Domestic Robots Has Arrived, China’s Endoscopic Surgical Robot Research Report | Industry Research
Standing on the Billion-Dollar Windfall of Domestic Surgical Robots: The Side Battle of Technology, Patents, and Prices
Technology | Seven Trends in Surgical Robot Motion Control
How to Use Design Patents to Provide Additional Protection for Medical Robots?
Nine
Industry Infrastructure
Minimally Invasive® Robot Company TUMAI® Robot Mobile Training Display Platform Officially Launched
On December 31, 2021, the “Minimally Invasive® TUMAI® Robot Mobile Training Display Platform” independently developed by Shanghai Minimally Invasive Medical Robot (Group) Co., Ltd. (hereinafter referred to as “Minimally Invasive® Group”, 00853.HK) was officially launched at the headquarters of Minimally Invasive® Group. Leaders from the Shanghai Municipal People’s Congress Finance and Economic Committee, Shanghai Robot Industry Association, and Minimally Invasive® Group attended the event.
Minimally Invasive® Robot Company TUMAI® Robot Mobile Training Display Platform Officially Launched | Minimally Invasive Medical
“Tianji” Orthopedic Surgical Robot Clinical Application Demonstration Base Established at Guizhou Provincial Hospital
On January 8, a celebration ceremony for the hundred surgeries of the orthopedic robot was held at Guizhou Provincial People’s Hospital, where the “Tianji” orthopedic surgical robot clinical application demonstration base was officially established. The “Tianji” robot is a new generation of domestic orthopedic robot system capable of performing surgeries on limbs, pelvic fractures, and the entire spine (cervical, thoracic, lumbar, and sacral). The launch of this base marks the entry of Guizhou Provincial People’s Hospital’s orthopedics into the stage of digital intelligence development, benefiting patients with more precise, minimally invasive, safe, and intelligent treatment technologies, promoting the development of orthopedic technology in Guizhou Province.
Orthopedic Surgical Robot | “Tianji” Orthopedic Surgical Robot Clinical Application Demonstration Base Established at Guizhou Provincial Hospital | Base Construction | Laboratory
Asia’s First Clinical Pre-Trial Base for Surgical Robots
Established under the InnoHK Innovation Hong Kong R&D platform, the “Medical Robot Innovation Technology Center” officially opened in 2020, with an 8,000 square foot laboratory put into operation in 2021, featuring a simulated operating room equipped with advanced medical instruments such as MRI and stereotactic scanning, making it Asia’s first and the world’s second one-stop platform specifically designed for preclinical trials of surgical robots.
Asia’s First Clinical Pre-Trial Base for Surgical Robots | Base Construction
Medtronic X Academy Officially Launched in Chengdu
On January 15, 2022, Medtronic China announced the official launch of the “X Academy”, dedicated to guiding intelligent orthopedics and empowering clinical education. Based at Medtronic’s Chengdu Innovation Center, the academy aims to create a leading comprehensive academic platform for intelligent orthopedics in China, focusing on the standardization of robotic-assisted surgical operations through comprehensive training courses and extensive academic exchanges, supporting the high-quality development of intelligent and precise orthopedics in China.
Empowering Spine Robot Clinical Education Medtronic X Academy Officially Launched in Chengdu | Academic Platform
Recruitment
Welcome to apply to join the largest medical robot community in China | Group 4 Recruitment Ongoing
Related Articles
MedRobot Monthly Report | 62 Updates in the Medical Robotics Industry – December 2021
MedRobot Monthly Report | New Developments in the Medical Robotics Industry – November 2021
